Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 187,750 | 72,569 | 71,103 | 94,381 | 11,357 |
| Marketable Securities | 59,622 | 90,562 | 100,028 | 108,539 | N/A |
| Receivables | 262 | 1,216 | 6,834 | 6,718 | N/A |
| TOTAL | $254,081 | $167,281 | $180,980 | $212,314 | $12,531 |
| Non-Current Assets | |||||
| PPE Net | 20,626 | 20,468 | 21,706 | 22,492 | 1,311 |
| Investments And Advances | 3,000 | 8,000 | 14,995 | 3,011 | 0 |
| Intangibles | 89,432 | 27,942 | 26,900 | 26,488 | 0 |
| Other Non-Current Assets | 61,863 | 23,195 | 20,802 | 21,190 | 1,880 |
| TOTAL | $174,921 | $79,605 | $84,403 | $73,181 | $3,191 |
| Total Assets | $429,002 | $246,886 | $265,383 | $285,495 | $15,722 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,995 | 325 | 1,339 | 752 | 939 |
| Accrued Expenses | 15,674 | 9,023 | 12,288 | 14,939 | 1,250 |
| TOTAL | $22,809 | $14,849 | $20,303 | $23,264 | $2,427 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 95 | 3,786 | 4,935 | 5,808 | N/A |
| Other Non-Current Liabilities | 55,194 | 34,062 | 33,621 | 33,983 | 54,300 |
| TOTAL | $71,571 | $197,503 | $198,464 | $202,650 | $54,414 |
| Total Liabilities | $94,380 | $212,352 | $218,767 | $225,914 | $56,841 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,377 | 42,158 | 16,212 | 16,167 | 16,151 |
| Common Shares | 4 | 2 | 8 | 8 | N/A |
| Retained earnings | -128,829 | -525,634 | -511,094 | -494,479 | -47,207 |
| Other shareholders' equity | 11 | 1,246 | 439 | -140 | -7 |
| TOTAL | $334,622 | $34,534 | $46,616 | $59,581 | $-41,119 |
| Total Liabilities And Equity | $429,002 | $246,886 | $265,383 | $285,495 | $15,722 |